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Edited by Ivan SadowskiAbstract Nucleophosmin (NPM)/B23 is a multifunctional pro-
tein, involving in a wide variety of basic cellular processes,
including ribosome assembly, DNA duplication, nucleocytoplas-
mic traﬃcking, and centrosome duplication. It has previously
been shown that NPM/B23 localizes to centrosomes, and disso-
ciate from centrosomes upon phosphorylation by Cdk2/cyclin E.
However, detail characterization of centrosomal association of
NPM/B23 has been hampered by the lack of appropriate anti-
bodies that eﬃciently detects centrosomally localized NPM/
B23, as well as by apparent loss of natural behavior of NPM/
B23 when tagged with ﬂuorescent proteins. Here, by the use of
newly generated anti-NPM/B23 antibody, we conducted a care-
ful analysis of centrosomal localization of NPM/B23. We found
that NPM/B23 localizes between the paired centrioles of undu-
plicated centrosomes, suggesting the role of NPM/B23 in the
centriole pairing. Upon initiation of centrosome duplication,
some NPM/B23 proteins remain at mother centrioles of the
parental centriole pairs. We further found that inhibition of
Crm1 nuclear export receptor results in both accumulation of cy-
clin E at centrosomes and eﬃcient dissociation of NPM/B23
from centrosomes.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Nucleophosmin (NPM)/B23, also known as NO38 or numa-
trin, is a multifunctional phosphoprotein, and has been impli-
cated in a wide variety of cellular functions, including
ribosome assembly and pre-ribosomal RNA processing in
nucleolus [1–4], DNA duplication through forming complexes
with DNA polymerase a and RB [5–7], nucleocytoplasmic pro-
tein traﬃcking through directly binding to the nuclear localiza-
tion signals (NLS) of the target proteins [8–11], pre-mRNA
processing (Tarapore et al., manuscript submitted), and cen-
trosome duplication [12–15]. In addition, NPM/B23 has been
shown to possess several interesting properties, including
RNA-binding and molecular chaperoning activities [16–19].
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nase and cyclin-dependent kinases (CDK1/cyclin B, CDK2/cy-
clin E, and CDK2/cyclin A) [20–23]. Phosphorylation of NPM/
B23 localized at centrosomes by CDK2/cyclin E (and A) has
been shown to be critical for initiation of centrosome duplica-
tion [12–14].
The centrosome, a small non-membranous organelle nor-
mally localized around the nucleus, is composed of a pair of
centrioles and many surrounding proteins referred to as peri-
centriolar material (PCM). Some PCM proteins localize to
centrosomes transiently during the cell cycle, while some local-
izes to centrosome throughout the cell cycle. Each centriole of
the pair is structurally distinct; a mother centriole equipped
with appendages at the proximal end, which are important
for anchoring microtubules, and a daughter centriole that does
not possess the appendages, which are acquired at late G2
phase (reviewed in [24]). The centrosome functions as a micro-
tubule organizing center, establishing microtubule network
during interphase, and directing the formation of bipolar spin-
dles during mitosis (reviewed in [25,26]). Upon cytokinesis,
each daughter cell inherits one centrosome, hence the centro-
some must duplicate once during each cell cycle. Centrosome
duplication begins with physical separation of paired centri-
oles, followed by procentriole formation in the vicinity of each
preexisting centriole, and elongation of procentrioles and
recruitment of PCM. Initiation of centrosome duplication is
at least in part triggered by cyclin-dependent kinase 2
(CDK2)/cyclin E (reviewed in [27]), which is activated in late
G1 primarily by temporal expression of cyclin E (reviewed in
[28]). Several targets of CDK2/cyclin E in the initiation of cen-
trosome duplication have been identiﬁed, including NPM/B23,
Mps1, and CP110 [12,29,30]. CDK2/cyclin E (as well as A)
phosphorylates NPM/B23 on Thr199, which causes NPM/B23
to dissociate from centrosomes, leading to initiation of centro-
some duplication [12–14].
To date, despite the involvement of NPM/B23 in diverse
cellular events, there has been no detail characterization of
subcellular localization of NPM/B23 primarily due to two
reasons: (1) only few antibodies were commercially available,
and (2) ﬂuorescent protein (i.e., green or red ﬂuorescent pro-
teins)-tagging, a powerful tool to analyze subcellular locali-
zation of proteins, appears to alter the biological nature of
NPM/B23, partly because both N- and C-terminal ends of
NPM/B23 are important for its oligomerization and func-
tions [31,32]. Here, we generated several anti-NPM/B23 anti-
bodies against various epitopes spanning the murine NPM/
B23, and identiﬁed one antibody that eﬃciently detects
NPM/B23 localized at centrosomes. Using this antibody,blished by Elsevier B.V. All rights reserved.
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of NPM/B23. We found that NPM/B23 localizes between
the paired centrioles within the centrosome. Although the
majority of NPM/B23 dissociate from centrosomes upon
physical separation of centrioles as described previously
[12], some NPM/B23 remains speciﬁcally at mother centri-
oles. Thus, one of duplicated centrosomes is bound by
NPM/B23 through the rest of interphase. It has previously
found that Crm1 (also known as exportin1) nuclear export
receptor, which binds to Ran GTPase that plays an essential
role in the regulation of nucleocytoplasmic transport as well
as mitotic spindle assembly (reviewed in [33]), is involved in
the regulation of centrosome duplication [34]. For instance,
inhibition of Crm1 by chemical inhibitors results in uncon-
trolled splitting of centrioles and premature centrosome
duplication [34]. Similarly, expression of hepatitis B virus
(HBV) HBx protein, which has a functional nuclear export
signal (NES) motif utilizing the Crm1/Ran GTPase pathway
and binds and sequester Crm1 in the cytoplasm, also results
in uncontrolled centriole splitting and centrosome ampliﬁca-
tion [34]. We found that inhibition of Crm1 results in rapid
dissociation of NPM/B23 from centrosomes, and accumula-
tion of cyclin E at centrosomes, suggesting that Crm1 con-
trols centrosomal localization of NPM/B23 via suppressing
CDK2/cyclin E activity at centrosomes by preventing the
centrosomal localization of cyclin E.2. Materials and methods
2.1. Antibodies
PabN1 and PabC2 antibodies were generated in rabbit against the
mouse NPM/B23 peptide a.a. 23–38 and a.a. 224–238, respectively.
Both antibodies were puriﬁed with the respective antigen peptides.
Antigen peptide-puriﬁed PabN2 antibody was purchased from Cell
Signaling, Inc. MabC1 antibody is a gift from Dr. Chan. Anti-centrin
antibody is a gift from Dr. Salisbury. Rabbit anti-c-tubulin antibody
was generated in our laboratory, and mouse anti-c-tubulin antibody
(GTU-88) was purchased from Sigma Immunochemicals. Anti-cyclin
E (M-20) and anti-Crm1 (H-300) antibodies were purchased from San-
ta Cruz Biotech.2.2. Cells, transfection and drug treatment
Wild-type mouse skin ﬁbroblasts (MSFs) were prepared from
abdominal skins of an 8-week-old C57L male mouse, and maintained
in complete medium [DMEM supplemented with 10% fetal bovine ser-
um (FBS), penicillin (100 U/ml) and streptomycin (100 lg/ml)] in an
atmosphere containing 10% CO2. Plasmid transfection was performed
using Lipofectamin 2000 (Invitrogen).
2.3. Immunoblot analysis
Cells were washed three times with PBS and lysed in SDS/NP-40
lysis buﬀer [1% SDS, 1% NP-40, 50 mM Tris (pH 8.0), 150 mM
NaCl, 4 mM Pefabloc SC (Roche), 2 lg/ml leupeptin, 2 lg/ml apro-
tinin]. The lysates were boiled for 5 min, and cleared by a 10 min
centrifugation at 20000 · g at 4 C. The supernatant was denatured
at 95 C for 5 min in sample buﬀer [2% SDS, 10% glycerol, 60 mM
Tris (pH 6.8), 5% b-mercaptoethanol, 0.01% bromophenol blue].
Samples were resolved by SDS–PAGE, and transferred onto Immo-
bilon-P sheets (Millipore). The blots were incubated in blocking buf-
fer [5% (wt/vol) non-fat dried milk in Tris-buﬀered saline
(TBS) + Tween 20 (TBS-T)] for 1 h at room temperature. The blots
were incubated with primary antibody for overnight at 4 C, fol-
lowed by incubation with horseradish peroxidase-conjugated second-
ary antibody for 1 h at room temperature. The antibody–antigen
complex was visualized by ECL chemiluminescence (Amersham
Biosciences).2.4. Indirect immunoﬂuorescence
Cells grown on coverslips were ﬁxed with 10% formalin/10%
methanol for 20 min at room temperature. The cells were permeabi-
lized with 1% NP-40 in PBS for 5 min, followed by incubation with
blocking solution [10% normal goat serum in PBS] for 1 h. Cells
were then probed with primary antibodies for 1 h, and antibody–
antigen complexes were detected with either Alexa Fluor 488- or
Alexa Fluor 594-conjugated goat secondary antibody (Molecular
Probes) by incubation for 1 h at room temperature. The coverslips
were washed with PBS after each incubation, and then counter-
stained with 4 0,6-diamidino-2-phenylindole (DAPI). For triple-color
immunostaining for the experiment involving in transfection of
GFP-HBx, cells were co-immunostained with mouse anti-c-tubulin
and rabbit anti-NPM/B23 antibodies. The antigen–antibody com-
plexes were detected with Alexa Fluor 546-conjugated anti-mouse
IgG and Alexa Fluor 350-conjugated anti-rabbit IgG antibodies,
both of which do not overlap the peak ﬂuorescence emission spec-
trum with GFP. For immunostaining of centrosomally localized
Crm1, prior to ﬁxation cells were brieﬂy extracted in 0.75% Triton
X-100, 2 mM EGTA, 5 mM PIPES (pH 7.0) for 30 s followed by
brief wash with PBS (three times). This brief extraction, which re-
moves majority of cytoplasmic Crm1 unbound to macrostructures,
is necessary for clear visualization of Crm1 at centrosomes [34].
Immunostained cells were examined under a ﬂuorescence microscope
(Zeiss Axioplan 2 Imaging) or a Zeiss epiﬂuorescent microscope
with an ORCA-ER CCD camera using a 60· objective lens.
2.5. In vitro kinase assay
Cells were lysed in NP-40 lysis buﬀer [50 mM Tris (pH 8.0), 5 mM
MgCl2, 10 mM EGTA, 1% NP-40, 50 mM b-glycerophosphate,
50 mM NaF, 0.5% sodium deoxycholate, 1 mM PMSF, 2 lg/ml leu-
peptin, 2 lg/ml aprotinin]. The lysates were cleared by centrifugation
for 15 min at 20000 · g and 4 C. The supernatants were precleared
with protein A–agarose, and the lysates (500 lg of total proteins) were
immunoprecipitated with anti-cyclin E antibody (M-20, Santa Cruz
Biotech), and the antibody–antigen complexes were collected with pro-
tein A–agarose, and subjected to in vitro kinase assay using GST-
NPM/B23 as a substrate in the reaction mixture [20 mM HEPES
(pH 7.2), 10 mM MgCl2, 20 mM EGTA, 80 mM b-glycerophosphate,
200 lM dithiothreitol, 0.5 mM PMSF, 2 lg/ml leupeptin, 2 lg/ml
aprotinin, 50 lM cold ATP, and 0.22 lM [c-32P] ATP] at 33 C for
30 min. The samples were resolved by SDS–PAGE, and the gel was
stained with Coomassie blue, dried and autoradiographed.3. Results
3.1. Subcellular localization of NPM/B23 characterized by
diﬀerent antibodies
Using commercially available antibodies as well as antibod-
ies generated in our laboratory, we analyzed the subcellular
localization of NPM/B23. The four antibodies described in this
study are shown in Fig. 1A, panel b. Two polyclonal antibod-
ies (PabN1 and PabN2) recognize the N-terminal regions, and
one polyclonal (PabC2) and one monoclonal (MabC1) recog-
nize the C-terminal regions. These antibodies, except for
MabC1, were aﬃnity-puriﬁed using the epitope peptides. All
antibodies show a high degree of speciﬁcity to NPM/B23,
determined by immunoblot analysis of cell lysates derived
from primary MSFs prepared from abdominal skins of C57L
male mice (Fig. 1B).
We co-immunostained early passage primary MSFs with the
anti-NPM/B23 antibodies together with anti-c-tubulin anti-
body that detects centrosomes (Fig. 1C). As described previ-
ously, MabC1 primarily recognizes NPM/B23 localized in
nucleolus, and those at centrosomes and in nucleoplasm
weakly (panels a–d, see magniﬁed images in panels 1–3). In
contrast, PabN1 strongly reacts with NPM/B23 localized at
centrosomes, and those in nucleolus as well as in nucleoplasm
Fig. 1. Characterization of anti-NPM/B23 antibodies. (A) Schematic description of speciﬁc features of NPM/B23 (a) and epitope maps of the various
anti-NPM/B23 antibodies (b). (B) Characterization of anti-NPM/B23 antibodies by immunoblot analysis. The whole cell lysates prepared from
MSFs were immunoblotted with indicated antibodies. (C) Immunocytochemical characterization of anti-NPM/B23 antibodies. MSFs were co-
immunostained with anti-c-tubulin (panels b, f, j, n) and indicated anti- NPM/B23 (panels c, g, k, o) antibodies. Cells were also stained for DNA by
DAPI (panels a, e, i, m). Panels d, h, l and p show the merged images of c-tubulin and NPM/B23 staining. Panels 1–6 show the magniﬁed images of
the area indicated by the blue arrows. White arrows point to the positions of centrosomes. Scale bar, 10 lm.
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These observations suggest that NPM/B23 localized in nucleo-
lus and at centrosomes may be structurally distinct, which
could be due to diﬀerent post-translational modiﬁcations, dif-
ferent self-oligomerization status, or complex formation with
other proteins. PabN2 (panels i–l) and PabC2 (panels m–p)
did not discernibly react with NPM/B23 at centrosomes nor
in nucleolus, suggesting that the a.a. sequences 40–107 and
224–238 may be masked either by protein folding or physical
association with other proteins.
3.2. NPM/B23 localizes between the paired centrioles of
unduplicated centrosomes
The previous studies using MabC1 anti-NPM/B23 antibody
have shown that NPM/B23 localizes to unduplicated centro-
somes in early-mid G1 phase. Upon phosphorylation by
CDK2/cyclin E, NPM/B23 dissociates from centrosomes,
which leads to physical separation of the paired centrioles
[12,13]. Since PabN1 anti-NPM/B23 antibody eﬃciently recog-
nizes NPM/B23 localized at centrosomes, it gave us the oppor-
tunity to analyze the centrosomal association of NPM/B23
closely. We co-immunostained early-mid G1 phase MSFs (en-
riched by serum-starvation followed by serum-stimulation for
6 h) using PabN1 anti-NPM/B23 antibody and anti-centrin
antibody that can distinguishingly immunostain each centriole
of the pair (Fig. 2A). Highly magniﬁed images of immuno-
stained cells revealed that NPM/B23 is localized between the
two centrioles in most (70%) cases (Fig. 2A, panel e). At low-
er frequency (30%), NPM/B23 was found toward one of the
centriole pair (panel j). To extend the ﬁnding of the unique
subcentrosomal localization of NPM/B23, MSFs co-immuno-
stained for NPM/B23 and either centrin or c-tubulin were sub-
jected to three-dimensional reconstruction of magniﬁed
deconvoluted microscopic images (Fig. 2B). We found that
NPM/B23 indeed localized between two centrioles detected
by both anti-c-tubulin (panel a) and anti-centrin (panel b) anti-
bodies.
To gain further insight on the sub-centrosomal localization
of NPM/B23 (between the two paired centrioles vs. toward
one of the centriole pair), MSFs were synchronized by ser-
um-starvation followed by serum-stimulation. One of the par-
allel cultures were incubated in the presence of BrdU to
monitor the cell cycle progression (Fig. 2C, a). Cells in the
other culture were co-immunostained with anti-centrin and
anti-NPM/B23 PabN1 antibodies, and sub-centrosomal local-
ization of NPM/B23 in the unduplicated centrosomes was
examined (Fig. 2C, b). We found the shift in the sub-centro-
somal localization of NPM/B23 during G1 progression. In
early G1, majority of NPM/B23 localized between the paired
centrioles. However, NPM/B23 started to localize toward
one of the paired centrioles progressively as G1 progressed,
suggesting that the changes in the sub-centrosomal localization
of NPM/B23 from between the paired centrioles to toward one
of the centrioles may precede the initiation of centrosome
duplication.
3.3. Centrosomal association of NPM/B23 during the cell cycle
Using PabN1 anti-NPM/B23 antibody, we conducted a care-
ful analysis of the cell cycle-dependent changes in centrosome
association of NPM/B23. MSFs synchronized by serum-star-
vation followed by serum-stimulation were ﬁxed at every 6 h
for a period of 24 h, and co-immunostained with anti-NPM/B23 (PabN1) and anti-c-tubulin antibodies (Fig. 3). During
S phase, two duplicated centrosomes exist relatively close to
each other (panels a1–a4). Surprisingly, PabN1 antibody de-
tected NPM/B23 at one of two duplicated centrosomes in all
of the cells examined, although the intensity of the immunoﬂu-
oresence signals were generally much weaker than that found
on unduplicated centrosomes (see the magniﬁed merged image
in panel a5), indicating that the majority of NPM/B23 local-
ized at unduplicated centrosomes dissociate from centrosomes
as described previously [12], but some portions of NPM/B23
remain at one of the duplicated centrosomes. During G2
(panels b1–b4) and at G2/M transition identiﬁed by the migra-
tion of centrosomes to the polar axis (panels c1–c4), NPM/B23
was found on one of the two duplicated centrosomes (see mag-
niﬁed merged images in panels b5, b6, c5 and c6). Once cells
enter mitosis, PabN1 antibody can no longer detect NPM/
B23 at centrosomes (prometaphase d1–d6, metaphase e1–e5,
anaphase f1–f6). This is likely due to masking of the N-termi-
nal PabN1 antibody epitope by either structural changes of
NPM/B23 itself or by association with other proteins, since
MabC1 anti-NPM/B23 antibody is able to detect NPM/B23
at both spindle poles (centrosomes) during mitosis [12,35].
At telophase and cytokinesis, PabN1 antibody detects NPM/
B23 at both centrosomes (panels g1–g6). The signal intensity
of NPM/B23 in cells undergoing telophase/cytokinesis (see
panel g3) is as strong as that found on unduplicated centro-
somes. Thus, in consistent with the previous ﬁndings [12],
NPM/B23 accumulates at centrosomes during mitosis, hence
each daughter cell after cytokinesis has one centrosome bound
by full amounts of NPM/B23. Moreover, temporal disappear-
ance of the PabN1 epitope at centrosomes during mitosis in
spite of the presence of NPM/B23 suggests that NPM/B23
undergoes dynamic structural changes during mitosis.
3.4. Low levels of NPM/B23 remains speciﬁcally associated with
mother centrioles upon physical separation of the paired
centrioles
The initial event of the centrosome duplication process is
physical splitting of the centriole pair. The studies described
above show that NPM/B23 remains at one of the centriole pair
upon centriole splitting. To test whether NPM/B23 speciﬁcally
associate with a mother or daughter centriole, we co-immuno-
stained MSFs for NPM/B23 and either cenexin or acetylated
a-tubulin. Cenexin is present speciﬁcally on the mature mother
centriole, and is acquired by the daughter centriole at G2/M
transition [36], and thus immunostaining of cenexin detects
only mother centrioles in interphase cells. In contrast, immu-
nostaining of acetylated a-tubulin detects small primary cilia
nucleated only by mother centrioles, hence allowing to identify
the mother centrioles [37,38]. Co-immunostaining of NPM/
B23 and cenexin revealed that the dot signals detected by
anti-NPM/B23 antibody (PabN1) always colocalizes with the
dot signals detected by anti-cenexin antibody (Fig. 4A), indi-
cating that NPM/B23 speciﬁcally localizes to mother centri-
oles. Immunostaining of acetylated a-tubulin detects two
centrioles, yet also detects a primary cilium nucleated from
mother centrioles (see Fig. 4B, see a magniﬁed image in panel
II, in which mother centriole with a cilium is indicated by an
arrow). Co-immunostaining with anti-NPM/B23 antibody
revealed that NPM/B23 always localized to the centriole with
a cilium, when two centrioles are separated with a discernible
distance (Fig. 4B, panels a–d and I–III). Thus, when centrioles
Fig. 2. Detail characterization of sub-centrosomal localization of NPM/B23 by PabN1 anti-NPM/B23 antibody. (A) MSFs were co-immunostained
with anti-centrin (panels a and f) and PabN1 anti-NPM/B23 (panels b and g) antibodies. Cells were also stained for DNA with DAPI (panels c and
h). Panels d and i show the superimposed images. Panels e and j show the magniﬁed images of the areas indicated by blue arrows. White arrows point
to the positions of centrosomes. Scale bar, 10 lm. (B) Three-dimensional (3D) reconstruction of deconvoluted images of NPM/B23 at centrosomes.
MSFs were co-immunostained for either anti-c-tubulin (panel a) or anti-centrin (panel b) antibody together with PabN1 anti-NPM/B23 antibody. Z-
stack images taken for centrin or c-tubulin and NPM/B23 staining images were deconvoluted and merged. (C) Parallel cultures of MSFs were serum-
starved for 24 h, and growth-stimulated with media supplemented with 20% serum. One of the cultures was incubated with BrdU, and the rate of
BrdU-incorporation was determined at every 5 h for a period of 20 h (a). Cells in the other cultures were ﬁxed at 3, 6, 12, and 18 h, and
co-immunostained with anti-c-tubulin and anti-NPM/B23 (PabN1) antibodies. Unduplicated centrosomes in these cells were then examined for the
sub-centrosomal localization of NPM/B23 (between the paired centrioles vs. toward one of the centriole) (b). The results are shown as the
average ± standard error from three independent experiments.
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ciﬁcally with mother centrioles.
3.5. Crm1 activity is involved in the control of centrosomal
localization of NPM/B23
It has previously been shown that the nuclear export recep-
tor Crm1 is involved in the regulation of centrosome duplica-
tion. For instance, inhibition of Crm1 either by Crm1-speciﬁc
inhibitor leptomycin B (LMB) or by expression of HBV HBxprotein induces uncontrolled centriole splitting and centro-
some duplication [34]. Since NPM/B23 localizes between the
paired centrioles, and is likely involved in the centriole pairing,
we hypothesized that NPM/B23 might be a downstream target
of Crm1 in the regulation of centriole pairing. To test this, we
ﬁrst treated MSFs with LMB for 24 h, and co-immunostained
with anti-c-tubulin and anti-NPM/B23 (PabN1) antibodies. As
previously shown [34], LMB-treatment induced an increase in
the frequency of centrosome ampliﬁcation (P3 centrosomes)
Fig. 3. Characterization of centrosomal association of NPM/B23 during the cell cycle. MSFs were synchronized by serum-starvation followed by
serum-stimulation. At every 6 h after serum-stimulation, cells were ﬁxed and co-immunostained with anti-c-tubulin (panels a2–g2) and PabN1 anti-
NPM/B23 (panels a3–g3) antibodies. Cells were also stained for DNA with DAPI (panels a1–g1). Panels a4–g4 show the merged images. Smaller
panels on the right show the magniﬁed images of the area indicated by arrows. Determination of the interphase cell cycle stages were approximated
from the BrdU-incorporation assay and ﬂow cytometric analysis of the parallel cultures (not shown), as well as centrosome morphologies (i.e.,
unduplicated, duplicated, and positions of duplicated centrosomes), since the centrosome and DNA duplication cycles are highly coordinated in the
primary MSFs used in this study.
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well as duplicated centrosomes bound by NPM/B23 (Fig. 5B).
In this analysis, we excluded the cells with ampliﬁed centro-
somes, since it is diﬃcult to identify whether those ampliﬁed
centrosomes represent unduplicated or duplicated centrosomes(see Fig. 5D). In the untreated control cells, NPM/B23 was
found in all unduplicated and duplicated centrosomes (at
one of the duplicated centrosomes). In contrast, in the LMB-
treated cells, only 50% of both unduplicated and duplicated
centrosomes were bound by NPM/B23. The representative
Fig. 4. NPM/B23 remains speciﬁcally at mother centrioles after centriole splitting. MSFs were co-immunostained with either anti-cenexin (A, panel
c) or anti-acetylated a-tubulin (B, panel c) antibodies together with PabN1 anti-NPM/B23 antibody (A and B, panel b). Cells were also stained for
DNA with DAPI (A and B, panel a). Panel d in both (A) and (B) show the merged images. Panels I–III in (A) and (B) show the magniﬁed images of
the indicated areas. White arrows in (B) point to the positions of the ciliated mother centriole. Scale bar, 10 lm.
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of Crm1 by LMB induces dissociation of NPM/B23 from cen-
trosomes.
LMB-treatment is known to induce uncontrolled centriole
splitting and centrosome duplication, hence in the LMB-trea-
ted cells, some ampliﬁed centrosomes contain paired centri-
oles, and some contain a single centriole [34]. We, thus,
examined the sub-centrosomal localization of NPM/B23 in
cells with ampliﬁed centrosomes after LMB-treatment. To this
end, MSFs stably expressing GFP-tagged centrin (a centriole
marker protein) were treated with LMB for 24 h, and immuno-
stained with anti-NPM/B23 antibody (Fig. 5D). Some intact
centrosomes (containing paired centrioles) were bound by
NPM/B23, while some were free of NPM/B23 (intact centro-
somes are indicated by yellow arrows). Strikingly, >95% of
the physically separated centrioles (indicated by white arrows)
were free of NPM/B23. This observation further suggests that
Crm1 inhibition promotes dissociation of NPM/B23 from cen-
trosomes, and that dissociation of NPM/B23 from centro-
somes in turn promotes physical separation of centrioles.
To corroborate the above ﬁnding, we next transfected MSFs
with a plasmid encoding GFP-tagged HBV HBx. HBx is
known to sequester Crm1 in cytoplasm, and thus inhibits the
Crm1 activity [39]. As a control, a GFP-vector was transfected.At 36 h post-transfection, cells were ﬁrst co-immunostained
with anti-Crm1 antibody to conﬁrm the shift of nuclear to
cytoplasmic localization of Crm1 by GFP-HBx expression
(Fig. 6A). In the GFP-vector-transfected cells, Crm1 mostly
localized in the nucleus (panel b). In contrast, in the GFP-
HBx-transfected cells, signiﬁcant portions of Crm1 redistrib-
uted to cytoplasm with concomitant decrease in the level of
nuclear Crm1 (panel e). Thus, GFP-HBx can sequester Crm1
in cytoplasm, although not completely. The transfectants were
then co-immunostained with anti-c-tubulin (mouse) and anti-
NPM/B23 (PabN1) (rabbit) antibodies. The antigen–antibody
complexes were detected with Alexa Fluor 546-conjugated
anti-mouse IgG and Alexa Fluor 350-conjugated anti-rabbit
IgG antibodies, both of which do not overlap the peak ﬂuores-
cence emission spectrum with GFP moieties. The GFP-positive
cells were then microscopically analyzed. Although less eﬃ-
cient than the LMB-treatment, HBx expression induced a
noticeable increase in the frequency of centrosome ampliﬁca-
tion (Fig. 6B). We then examined the centrosomal localization
of NPM/B23 in GFP-positive cells (Fig. 6C, representative
immunostaining images are shown in Fig. 6D). In the control
GFP-vector-transfected cells, NPM/B23 was at the centro-
somes in almost all cases. In contrast, there was a signiﬁcant
reduction in the number of NPM/B23-bound centrosomes,
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observations further suggest the involvement of Crm1 in the
regulation of centrosomal localization of NPM/B23.
In our study, centrosome ampliﬁcation as well as dissocia-
tion of NPM/B23 from centrosomes was more eﬀectively in-
duced by LMB-treatment than HBx expression. It is diﬃcult
to compare the eﬀects of LMB-treatment and HBx expression,Fig. 5. Crm1 inhibition by LMB results in dissociation of NPM/B23 from cen
untreated and LMB-treated cells were immunostained for centrosomes using
determined (A). The results are shown as average ± standard error from three
untreated and LMB-treated cells were also co-immunostained with anti
localization of NPM/B23 at unduplicated and duplicated centrosomes was d
were excluded. The results are shown as average ± standard error from t
representative immunostaining images are shown in (C). The panels on the ri
arrows. White arrows point to the positions of centrosomes. Scale bar, 10 lm
(10 nM) for 24 h, and were immunostained with PabN1 anti-NPM/B23 antib
were then examined. The centrosomes with a paired centrioles are pointed by
Magniﬁed images of the indicated areas are also shown. Scale bar, 10 lm.since HBx was transiently transfected, hence the level of HBx
expression in each transfectant could vary among the transfec-
tants. Beside such argument, it may alternatively be that LMB
may inhibit Crm1s activity to control centrosome duplication
more eﬀectively than HBx. For instance, Crm1 has been shown
to localize at centrosomes, and LMB-treatment results in dis-
sociation of Crm1 [34]. Thus, less eﬃcient dissociation oftrosomes. MSFs were treated with LMB (10 nM) for 24 h. The control
anti-c-tubulin antibody, and the number of centrosomes per cell was
experiments. Each experiment, >300 cells were examined. The control
-c-tubulin and PabN1 anti-NPM/B23 antibodies, and centrosomal
etermined (B). In this analysis, cells with ampliﬁed (P3) centrosomes
hree experiments. Each experiment, >200 cells were examined. The
ght (e, j, o, t) show the magniﬁed images of the areas indicated by blue
. (D) The MSFs stably expressing GFP-centrin were treated with LMB
ody, and counterstained with DAPI. Cells with ampliﬁed centrosomes
yellow arrows, and the physically separated centrioles by white arrows.
K. Shinmura et al. / FEBS Letters 579 (2005) 6621–6634 6629NPM/B23 and induction of centrosome duplication by GFP-
HBx may be simply reﬂecting that HBx may be less eﬀective
for dislodging Crm1 from centrosomes than LMB-treatment.
To test this possibility, we co-immunostained the cells treated
with LMB for 24 h as well as cells transfected with GFP-HBx
(36 h post-transfection) with anti-c-tubulin and anti-Crm1
antibodies (Fig. 7A, representative immunostaining images
are shown in B). For immunostaining of the GFP-HBx-trans-Fig. 6. Crm1 inhibition by HBx expression induces dissociation of NPM/B2
tagged HBx. As a control, GFP-vector was transfected. The transfected cell
Crm1 antibody (panels b and e), and counterstained with DAPI (panels c and
bar, 10 lm. (B) The transfectants were also immunostained for centrosomes
GFP-positive cell was determined. The results are shown as average ± stan
examined. (C) The transfectants were also co-immunostained with anti-c-
antigen–antibody complexes were detected with Alexa Fluor 546-conjugat
antibodies, both of which do not overlap the peak ﬂuorescence emission sp
centrosomal localization of NPM/B23 at unduplicated and duplicated centr
excluded due to the diﬃculty to identify whether those represent un
average ± standard error from three experiments. Each experiment, >200
shown in (D). The control GFP vector-transfected cells are shown in panels
panels on the right show the magniﬁed images of the areas indicated by blue
5 lm.fectants, the secondary antibodies that do not overlap the peak
ﬂuorescence emission spectrum with GFP were used as de-
scribed in the legend to Fig. 6D, and successfully transfected
cells were identiﬁed by the autoﬂuorescence of GFP-moiety
of GFP-HBx. In both unduplicated and duplicated centro-
somes, LMB-treatment resulted in more eﬃcient dissociation
of Crm1 from centrosomes (90% of Crm1-bound centro-
somes in untreated cells to 40% in LMB-treated cells) than3 from centrosomes. (A) MSFs were transiently transfected with GFP-
s were ﬁxed at 36 h post-transfection, and immunostained using anti-
f). Panels a and d show the autoﬂuorescence of the GFP moieties. Scale
using anti-c-tubulin antibody, and the number of centrosomes in each
dard error from three experiments. Each experiment, >300 cells were
tubulin (mouse) and PabN1 anti-NPM/B23 (rabbit) antibodies. The
ed anti-mouse IgG and Alexa Fluor 350-conjugated anti-rabbit IgG
ectrum with GFP. The immunostained cells were then examined for
osomes. In this analysis, cells with ampliﬁed (P 3) centrosomes were
duplicated or duplicated centrosomes. The results are shown as
cells were examined. The representative immunostaining images are
a–d, and the GFP-HBx-transfected cells are shown in panels e–k. The
arrows. White arrows point to the positions of centrosomes. Scale bar,
6630 K. Shinmura et al. / FEBS Letters 579 (2005) 6621–6634HBx expression (90% of Crm1-bound centrosomes in the
GFP-vector-transfected cells to 60% in the GFP-HBx-trans-
fected cells). Thus, the less eﬀective dislodgement of Crm1
from centrosomes by HBx may account for the less eﬃcient
dissociation of NPM/B23 from centrosomes and centrosome
ampliﬁcation by HBx compared with LMB-treatment.
3.6. Crm1 inhibition results in accumulation of cyclin E at
centrosomes
Since most of NPM/B23 proteins dissociate from centro-
somes by Cdk2/cyclin E-mediated phosphorylation [12–14],
we next tested whether inhibition of Crm1 aﬀects the overallFig. 7. LMB-treatment results in more eﬃcient dissociation of Crm1 from c
for 24 h, or transiently transfected with GFP-HBx. LMB-treated cells and
prior to ﬁxation (see Section 2). The brief extraction to remove cytoplasmical
localized Crm1. After ﬁxation, cells were co-immunostained with anti-c-tubu
conjugated goat secondary antibodies were used for the LMB-treated cells, a
conjugated anti-rabbit IgG antibodies, both of which do not overlap the pe
HBx-transfectants. Unduplicated and duplicated centrosomes in cells were ex
error from three independent experiments) are shown in (A). For each expe
images are shown in (B). Arrows point to the position of centrosomes. The in
bar, 10 lm.Cdk2/cyclin E activity. To this end, MSFs were treated with
LMB for 24 h, and lysates were prepared from LMB-treated
and untreated cells. The cell lysates were then subjected to
immunoprecipitation using anti-cyclin E antibody. The immu-
noprecipitates containing cyclin E as well as Cdk2/cyclin E
complexes were subjected to in vitro kinase assay using bacte-
rially puriﬁed GST-NPM/B23 as a substrate (Fig. 8A). GST
was also tested as a substrate for control. We found that there
was no signiﬁcant diﬀerence in the overall Cdk2/cyclin E
activities between untreated and LMB-treated cells, indicating
that inhibition of Crm1 does not inﬂuence the activity of Cdk2/
cyclin E.entrosomes than HBx expression. MSFs were either treated with LMB
GFP-HBx-transfectants (36 h post-transfection) were brieﬂy extracted
ly localized free Crm1 is critical for clear visualization of centrosomally
lin and anti-Crm1 antibodies. Alexa Fluor 488- and Alexa Fluor 594-
nd Alexa Fluor 546-conjugated anti-mouse IgG and Alexa Fluor 350-
ak ﬂuorescence emission spectrum with GFP, were used for the GFP-
amined for co-localization of Crm1, and the results (average ± standard
riment, >200 cells were examined. The representative immunostaining
sets show the magniﬁed images of the areas indicated by arrows. Scale
Fig. 8. Crm1 inhibition by LMB leads to accumulation of cyclin E at centrosomes. (A) Crm1 inhibition does not alter CDK2/cyclin E activity. MSFs
were treated with LMB (10 nM) for 24 h. The lysates were prepared from the control untreated and LMB-treated cells, and subjected to
immunoprecipitation with anti-cyclin E antibody. The immunoprecipitates were then subjected to in vitro kinase assay using GST-NPM/B23 as a
substrate. The reaction mixtures were resolved by SDS–PAGE, and the gel was stained with Coomassie blue (left panel), and autoradiographed (right
panel). (B) Characterization of the cell cycle progression of MSFs and cyclin E expression kinetics. MSFs were serum-starved for 24 h, and growth-
stimulated in the media containing 20% serum. In one culture, BrdU was added to the media. At every 5 h after serum stimulation, cells in the culture
with BrdU were ﬁxed, and examined for BrdU-incorporation. The lysates were also prepared from the cells in other culures, and examined for cyclin
E levels by immunoblot analysis. The rates of BrdU-incorporation and changes in cyclin E expression levels quantitated by the densitometric analysis
were plotted in the graph. (C) Crm1 inhibition by LMB-treatment promotes centrosomal localization of cyclin E. MSFs were serum-starved for 24 h,
and serum-stimulated for 12 h. LMB was then added to one of the cultures, and incubated for additional 4 h. Cells were then co-immunostained for
c-tubulin and cyclin E, and the frequency of centrosomal localization of cyclin E was determined. The results are shown as average ± standard error
from three experiments. In each experiment, >200 cells were examined. The representative immunostaining images are shown in (D). The arrows
point to the positions of centrosomes. The small panel on the right of each panel shows the magniﬁed image of the area indicated by the arrow. Scale
bar, 5 lm. (E) The lysates prepared from the LMB-treated and untreated MSFs described above at 16 h serum-stimulation were immunoblotted with
anti-cyclin E antibody (top panel). The lysates were also immunoblotted with anti-b-tubulin antibody as a loading control (bottom panel).
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somes [40,41], we next examined whether Crm1 inhibition
aﬀects the centrosomal localization of cyclin E. Since cyclin
E expression peaks at late G1 phase of the cell cycle, MSFs
were synchronized by serum-starvation followed by serum-
stimulation. To monitor the kinetics of G1 progression,
BrdU was added to the media during serum-stimulation,
and cells were examined for BrdU-incorporation at several
time points (Fig. 8B). Between 10 and 15 h after serum-stim-
ulation, the majority of cells incorporated BrdU. We also
examined the expression of cyclin E by immunoblot analysis
of the lysates prepared from the cells in parallel cultures.
The levels of cyclin E were quantitated, and plotted on
the same graph (Fig. 8B). The kinetics of the changes in
the expression levels of cyclin E are closely paralleled with
that of BrdU-incorporation. From these data, we estimatedthe 12–16 h of serum-stimulation enriches mid to late G1
MSFs. Thus, at 12 h after serum-stimulation, MSFs were ex-
posed to LMB for 4 h. The LMB-treated and untreated con-
trol cells were then co-immunostained for c-tubulin and
cyclin E, and examined for the frequency of centrosomal
association of cyclin E (Fig. 8C). Initiation of centrosome
duplication occurs at similar time that DNA synthesis be-
gins, especially in primary cells such as MSFs using in this
study. Thus, if cells have duplicated centrosomes, it is likely
that those cells are already in S phase, and cyclin E in those
cells may have already been targeted by the proteolytic
machinery [42,43]. Thus, we selectively examined the undu-
plicated centrosomes. In the untreated control cells, 8%
of centrosomes are bound by a readily detectable level of cy-
clin E. In contrast, in the LMB-treated cells, 25% of cen-
trosomes are bound by cyclin E (Fig. 8C; representative
6632 K. Shinmura et al. / FEBS Letters 579 (2005) 6621–6634immunostaining images are shown in Fig. 8D). Since LMB-
treatment (Crm1 inhibition) has been reported to negatively
aﬀect the cell cycle progression [44], it is possible that the
accumulation of cyclin E at centrosomes by LMB-treatment
may be the consequence of the altered cell cycle progression
by LMB-treatment, hence reﬂecting the increase in the total
intracellular cyclin E levels. We thus examined the levels of
cyclin E in the untreated and LMB-treated (LMB was added
12–16 h of serum-stimulation) at 16 h serum-stimulation by
immunoblot analysis (Fig. 8E). The untreated and LMB-
treated cells expressed similar levels of cyclin E. Thus, cyclin
E accumulation at centrosomes in the LMB-treated cells is
not due to the increase in the total cellular levels of cyclin E.
Since it has been shown that transient HBx expression does
not signiﬁcantly aﬀect the cell cycle progression [34], we further
tested whether expression of HBx also results in accumulation
of cyclin E at centrosomes. MSFs were transfected with either
GFP-HBx or GFP-vector. At 18 h post-transfection, cells were
serum-starved for 24 h, and serum-stimulated for 15 h. The
GFP-vector and -HBx-transfectants were then coimmuno-
stained with anti-c-tubulin and anti-cyclin E antibodies. The
successfully transfected cells identiﬁed by the autoﬂuorescence
of the GFP moiety were examined for cyclin E localization at
unduplicated centrosomes (Fig. 9A, representative immuno-
staining images are shown in 9B). In the GFP-vector-transfec-
ted cells, 8% of centrosomes are bound by cyclin E. In
contrast, in the GFP-HBx-transfected cells, >20% of centro-
somes are bound by cyclin E. Thus, like LMB-treatment,
expression of HBx also results in promotion of centrosomal
localization of cyclin E, and thus Crm1 inhibition (and/or) dis-
lodgement of centrosomal Crm1 speciﬁcally promotes the cen-
trosomal association of cyclin E.Fig. 9. Crm1 inhibition by HBx expression results in accumulation of cyclin
HBx or GFP-vector. At 18 h post-transfection, cells were serum-starved for
transfected cells were then co-immunostained with anti-cyclin E and anti-c-tu
IgG antibodies were used to detect the antibody–antigen complexes. The fre
was determined by ﬂuorescence microscopy. The results are shown as average
cells were examined. The representative immunostaining images are shown in
on the right of each panel shows the magniﬁed image of the area indicated4. Discussion
NPM/B23 is involved in a number of diﬀerent cellular
events, including ribosome assembly, nucleocytoplasmic traf-
ﬁcking, DNA replication, mRNA processing and centrosome
duplication. Thus, NPM/B23 is expected to localize in a variety
of cellular compartments, and exist in a variety of structural
conformations (through self-oligomerization, association with
diﬀerent proteins as well as diﬀerent post-translational modiﬁ-
cations). However, there had been no detail characterization of
subcellular localization of NPM/B23. To date, the majority of
studies on NPM/B23 were focused on its function in the
nucleolus, including ribosome assembly, pre-ribosomal RNA
processing, and protein sequestrations [1–4,45–48]. This is pri-
marily because only few antibodies (i.e., MabC1 antibody used
in this study) are commercially available, which preferentially
detect nucleolar NPM/B23, and because ﬂuorescent protein-
tagging at either N- or C-terminus appears to alter the behav-
iors and functions of NPM/B23. We thus initiated a careful
analysis of subcellular localization of NPM/B23, especially of
those localized at centrosomes by use of commercially avail-
able antibodies as well as those generated in our laboratories.
Among the antibodies characterized, the PabN1 antibody eﬃ-
ciently detects centrosomally localized NPM/B23, and less eﬃ-
ciently reacts with NPM/B23 in the nucleolus. Using this
antibody, we carefully analyzed centrosomal association of
NPM/B23 during the cell cycle. Within unduplicated centro-
somes, NPM/B23 localizes between the paired centrioles. How-
ever, during G1 progression, NPM/B23 progressively changes
its sub-centrosomal localization to toward one of the paired
centrioles. When the paired mother and daughter centrioles
physically split upon initiation of centrosome duplication,E at centrosomes. MSFs were transiently transfected with either GFP-
24 h, and serum-stimulated for 15 h. The GFP-vector- and GFP-HBx-
bulin antibody. Alexa Fluor 546 (red) and 350 (blue)-conjugated anti-
quency of cyclin E-bound centrosomes (in unduplicated centrosomes)
± standard error from three experiments (A). In each experiment, >200
(B). The arrows point to the positions of centrosomes. The small panel
by the arrow. Scale bar, 5 lm.
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somes. However, some NPM/B23 proteins remain associated
with mother centrioles. Thus, during S and G2, one of the
two duplicated centrosomes, especially the one with the origi-
nal mother centriole, is bound by NPM/B23. At the onset of
mitosis, the PabN1 antibody no longer detects NPM/B23 at
centrosomes (spindle poles). However, this disappearance of
the PabN1 epitope is most likely not due to the dissociation
of NPM/B23 from centrosomes, since the other antibody
(MabC1) can detect NPM/B23 at both centrosomes [12,35].
Only at telophase/cytokinesis, PabN1 antibody detects NPM/
B23 at both centrosomes. Thus, NPM/B23 appears to undergo
dynamic structural changes through forming complexes with
other proteins and/or post-translational modiﬁcation such as
phosphorylation by Cdk1/cyclin B [8,13,20], which may result
in masking of the epitope of PabN1 antibody and exposing the
epitope of MabC1 antibody. Indeed, during mitosis, centro-
somes are known to recruit many proteins, and the centro-
somes become enlarged signiﬁcantly compared with the
interphase centrosomes. It should be noted here that we tested
the PabN1 antibody on other mouse cell lines, including
NIH3T3, Swiss3T3, and primary mouse embryonic ﬁbroblasts
(MEFs), and found that the PabN1 antibody detects centro-
somal NPM/B23 in all the cell lines tested as eﬃciently as in
MSFs. However, because of the critical amino acid diﬀerence
in the epitope sequence of this antibody between the mouse
and human NPM/B23, the PabN1 antibody does not react
with human NPM/B23.
Localization of NPM/B23 between the paired centrioles in
the unduplicated centrosomes provides supporting evidence
for the previous observation implicating NPM/B23 in the pair-
ing of centrioles [12]. For instance, dissociation of NPM/B23
from centrosomes triggered by CDK2/cyclin E-mediated phos-
phorylation results in physical separation of the paired centri-
oles, which is the initial step for centrosome duplication. In
this context, NPM/B23 functions as a suppressor of centro-
some duplication. Indeed, it has recently been shown that
MEFs derived from NPM/B23/ mice as well as homozygous
hypomorphic NPM/B23 (NPM/B23hy/hy) mice, which show
reduction of NPM/B23 levels to 10–30% of wild-type, suﬀer
extensive centrosome ampliﬁcation and associated genomic
instability [15].
It has previously shown that inhibition of Crm1, an export
receptor that binds to NES of target proteins, results in uncon-
trolled centriole separation and centrosome ampliﬁcation [34].
Here, we found that inhibition of Crm1 results in eﬃcient dis-
sociation of NPM/B23 from centrosomes. Moreover, inhibi-
tion of Crm1 by LMB as well as expression of hepatitis B
virus HBx protein resulted in accumulation of cyclin E at cen-
trosomes. It is unlikely that centrosomal accumulation of cy-
clin E is due to alteration of the cell cycle progression by
Crm1 inhibition and the consequential increase of the total cel-
lular cyclin E levels. For instance, in our experiment, there was
no noticeable diﬀerence in the total cyclin E levels between syn-
chronized cells treated with LMB for a short period of time
and untreated cells at the time of examination of centrosomal
association of cyclin E (Fig. 8). Moreover, a short term HBx
expression, which does not disturb cell cycle progression [34],
also resulted in accumulation of cyclin E at centrosomes. Thus,
Crm1 inhibition speciﬁcally promotes the centrosomal associ-
ation of cyclin E. The molecular mechanism underlying the
promotion of centrosomal association of cyclin E by inhibitionof Crm1 is currently unknown. Although cyclin E has been
shown to continuously shuttle between nucleus and cytoplasm,
it does so in a Crm1-independent manner [49]. Thus, the pro-
motion of centrosomal association of cyclin E by Crm1 inhibi-
tion is unlikely related to the nucleocytoplasmic shuttling of
cyclin E. Since Crm1 itself localizes to centrosomes, and
LMB-treatment as well as HBx expression promotes dissocia-
tion of Crm1 from centrosomes [34, this study], dislodgement
of Crm1 from centrosomes may either directly or indirectly al-
low cyclin E to stably localize at centrosomes. Such possibility
is currently tested in out laboratory. In any case, since dissoci-
ation of NPM/B23 from centrosomes is triggered by CDK2/
cyclin E-mediated phosphorylation at centrosomes, accumula-
tion of cyclin E at centrosomes may be at least one of the
mechanisms underlying how inhibition of Crm1 leads to disso-
ciation of NPM/B23 from centrosomes, and subsequent centri-
ole separation. However, an alternative mechanism has been
recently reported, in which Crm1 directly controls the centro-
somal localization of NPM/B23 via physically associating with
NES of NPM/B23 [50]. Thus, Crm1 appears to act on multiple
pathways to control centrosomal localization of NPM/B23,
and thus to regulate centrosome duplication to occur in a
timely manner during the cell cycle.
Acknowledgments: We thank G. Ris for technical assistance. This re-
search is supported in part by the grant from National Institute of
Health (CA95925).References
[1] Spector, D.L., Ochs, R.L. and Busch, H. (1984) Silver staining,
immunoﬂuorescence, and immunoelectron microscopic localiza-
tion of nucleolar phosphoproteins B23 and C23. Chromosoma 90,
139–148.
[2] Yung, B.Y., Busch, H. and Chan, P.K. (1985) Translocation of
nucleolar phosphoprotein B23 (37 kDa/pI 5.1). induced by
selective inhibitors of ribosome synthesis. Biochim. Biophys. Acta
826, 167–173.
[3] Herrera, J.E., Savkur, R. and Olson, M.O. (1995) The ribonucle-
ase activity of nucleolar protein B23. Nucleic Acids Res. 23, 3974–
3979.
[4] Savkur, R.S. and Olson, M.O. (1998) Preferential cleavage in pre-
ribosomal RNA byprotein B23 endoribonuclease. Nucleic Acids
Res. 26, 4508–4515.
[5] Umekawa, H., Sato, K., Takemura, M., Watanabe, Y., Usui, S.,
Takahashi, T., Yoshida, S., Olson, M.O. and Fruichi, Y. (2001)
The carboxyl terminal sequence of nucleolar protein B23.1 is
important in its DNA polymerase alpha-stimulatory activity. J.
Biochem. 130, 199–205.
[6] Takemura, M., Sato, K., Nishio, M., Akiyama, T., Umekawa, H.
and Yoshida, S. (1999) Nucleolar protein B23.1 binds to
retinoblastoma protein and synergistically stimulates DNA poly-
merase alpha activity. J. Biochem. 125, 904–909.
[7] Okuwaki, M., Iwamatsu, A., Tsujimoto, M. and Nagata, K.
(2001) Identiﬁcation of nucleophosmin/B23, an acidic nucleolar
protein, as a stimulatory factor for in vitro replication of
adenovirus DNA complexed with viral basic core proteins. J.
Mol. Biol. 311, 41–55.
[8] Borer, R.A., Lehner, C.F., Eppenberger, H.M. and Nigg, E.A.
(1989) Major nucleolar proteins shuttle between nucleus and
cytoplasm. Cell 56, 379–390.
[9] Valdez, B.C., Perlaky, L., Henning, D., Saijo, Y., Chan, P.K. and
Busch, H. (1994) Identiﬁcation of the nuclear and nucleolar
localization signals of the protein p120. Interaction with translo-
cation protein B23. J. Biol. Chem. 269, 23776–23783.
[10] Szebeni, A., Herrera, J.E. and Olson, M.O. (1995) Interaction of
nucleolar protein B23 with peptides related to nuclear localization
signals. Biochemistry 34, 8037–8042.
6634 K. Shinmura et al. / FEBS Letters 579 (2005) 6621–6634[11] Szebeni, A., Mehrotra, B., Baumann, A., Adam, S.A., Wingﬁeld,
P.T. and Olson, M.O. (1997) Nucleolar protein B23 stimulates
nuclear import of the HIV-1 Rev protein and NLS-conjugated
albumin. Biochemistry 36, 3941–3949.
[12] Okuda, M., Horn, H.F., Tarapore, P., Tokuyama, Y., Smulian,
A.G., Chan, P.K., Knudsen, E.S., Hofmann, I.A., Snyder, J.D.,
Bove, K.E. and Fukasawa, K. (2000) Nucleophosmin/B23 is a
target of CDK2/cyclin E in centrosome duplication. Cell 103,
127–140.
[13] Tokuyama, Y., Horn, H.F., Kawamura, K., Tarapore, P. and
Fukasawa, K. (2001) Speciﬁc phosphorylation of nucleophosmin
on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in
centrosome duplication. J. Biol. Chem. 276, 21529–21537.
[14] Saavedra, H.I., Maiti, B., Timmers, C., Altura, R., Tokuyama,
Y., Fukasawa, K. and Leone, G. (2003) Inactivation of E2F3
results in centrosome ampliﬁcation. Cancer Cell 3, 333–346.
[15] Grisendi, S., Bernardi, R., Rossi, M., Cheng, K., Khandker, L.,
Manova, K. and Pandolﬁ, P.P. (2005) Role of nucleophosmin in
embryonic development and tumorigenesis. Nature 437, 147–153.
[16] Szebeni, A. and Olson, M.O. (1999) Nucleolar protein B23 has
molecular chaperone activities. Protein Sci. 8, 905–912.
[17] Dumbar, T.S., Gentry, G.A. and Olson, M.O. (1989) Interaction
of nucleolar phosphoprotein B23 with nucleic acids. Biochemistry
28, 9495–9501.
[18] Wang, D., Baumann, A., Szebeni, A. and Olson, M.O. (1994) The
nucleic acid binding activity of nucleolar protein B23.1 resides in
its carboxyl-terminal end. J. Biol. Chem. 269, 30994–30998.
[19] Okuwaki, M., Tsujimoto, M. and Nagata, K. (2002) The RNA
binding activity of a ribosome biogenesis factor, nucleophosmin/
B23, is modulated by phosphorylation with a cell cycle-dependent
kinase and by association with its subtype. Mol. Biol. Cell 13,
2016–2030.
[20] Peter, M., Nakagawa, J., Doree, M., Labbe, J.C. and Nigg, E.A.
(1990) Identiﬁcation of major nucleolar proteins as candidate
mitotic substrates of cdc2 kinase. Cell 60, 791–801.
[21] Chan, P.K., Liu, Q.R. and Durban, E. (1990) The major
phosphorylation site of nucleophosmin (B23) is phosphorylated
by a nuclear kinase II. Biochem. J. 270, 549–552.
[22] Jiang, P.S., Chang, J.H. and Yung, B.Y. (2000) Diﬀerent kinases
phosphorylate nucleophosmin/B23 at diﬀerent sites during G(2)
and M phases of the cell cycle. Cancer Lett. 153, 151–
160.
[23] Szebeni, A., Hingorani, K., Negi, S. and Olson, M.O. (2003) Role
of protein kinase CK2 phosphorylation in the molecular chaper-
one activity of nucleolar protein b23. J. Biol. Chem. 278, 9107–
9115.
[24] Bornens, M. (2002) Centrosome composition and microtubule
anchoring mechanisms. Curr. Opin. Cell Biol. 14, 25–34.
[25] Doxsey, S. (2001) Re-evaluating centrosome function. Nat. Rev.
Mol. Cell Biol. 2, 688–698.
[26] Fukasawa, K. (2002) Centrosomes: introduction. Oncogene 21,
6139–6145.
[27] Hinchcliﬀe, E.H. and Sluder, G. (2002) Two for two: Cdk2 and its
role in centrosome doubling. Oncogene 21, 6154–6160.
[28] Morgan, D.O. (1997) Cyclin-dependent kinases: engines, clocks,
and microprocessors. Annu. Rev. Cell Dev. Biol. 13, 261–
291.
[29] Fisk, H.A. and Winey, M. (2001) The mouse Mps1p-like kinase
regulates centrosome duplication. Cell 106, 95–104.
[30] Chen, Z., Indjeian, V.B., McManus, M., Wang, L. and Dynlacht,
B.D. (2002) CP110, a cell cycle-dependent CDK substrate,
regulates centrosome duplication in human cells. Dev. Cell 3,
339–350.
[31] Liu, Q.R. and Chan, P.K. (1991) Formation of nucleophosmin/
B23 oligomers requires both the amino- and the carboxyl-terminal
domains of the protein. Eur. J. Biochem. 200, 715–721.[32] Hingorani, K., Szebeni, A. and Olson, M.O. (2000) Mapping the
functional domains of nucleolar protein B23. J. Biol. Chem. 275,
24451–24457.
[33] Dasso, M. (2002) The Ran GTPase: theme and variations. Curr.
Biol. 12, R502–R508.
[34] Forgues, M., Diﬁlippantonio, M.J., Linke, S.P., Ried, T.,
Nagashima, K., Feden, J., Valerie, K., Fukasawa, K. and Wang,
X.W. (2003) Involvement of Crm1 in hepatitis B virus X protein-
induced aberrant centriole replication and abnormal mitotic
spindles. Mol. Cell. Biol. 23, 5282–5292.
[35] Zatsepina, O.V., Rousselet, A., Chan, P.K., Olson, M.O., Jordan,
E.G. and Bornens, M. (1999) The nucleolar phosphoprotein B23
redistributes in part to the spindle poles during mitosis. J. Cell Sci.
112, 455–466.
[36] Lange, B.M. and Gull, K. (1995) A molecular marker for
centriole maturation in the mammalian cell cycle. J. Cell Biol. 130,
919–927.
[37] Albrecht-Buehler, G. and Bushnell, A. (1980) The ultrastructure
of primary cilia in quiescent 3T3 cells. Exp. Cell Res. 126, 427–
437.
[38] Guarguaglini, G., Duncan, P.I., Stierhof, Y.D., Holmstrom, T.,
Duensing, S. and Nigg, E.A. (2005) The forkhead-associated
domain protein Cep170 interacts with Polo-like kinase 1 and
serves as a marker for mature centrioles. Mol. Biol. Cell 16, 1095–
1107.
[39] Forgues, M., Marrogi, A.J., Spillare, E.A., Wu, C.G., Yoshida,
M. and Wang, X.W. (2001) Interaction of the hepatitis B
virus X protein with the Crm1-dependent nuclear export pathway.
J. Biol. Chem. 276, 22797–22803.
[40] Hinchcliﬀe, E.H., Li, C., Thompson, E.A., Maller, J.L. and
Sluder, G. (1999) Requirement of Cdk2-cyclin E activity for
repeated centrosome reproduction in Xenopus egg extracts.
Science 283, 851–854.
[41] Matusmoto, Y. and Maller, J.L. (2004) A centrosomal localiza-
tion signal in cyclin E required for Cdk2-independent S phase
entry. Science 306, 885–888.
[42] Clurman, B.E., Sheaﬀ, R.J., Thress, K., Groudine, M. and
Roberts, J.M. (1996) Turnover of cyclin E by the ubiquitin-
proteasome pathway is regulated by cdk2 binding and cyclin
phosphorylation. Genes Dev. 10, 1979–1990.
[43] Won, K.A. and Reed, S.I. (1996) Activation of cyclin E/CDK2 is
coupled to sitespeciﬁc autophosphorylation and ubiquitin-depen-
dent degradation of cyclin E. EMBO J. 15, 4182–4193.
[44] Yoshida, M., Nishikawa, M., Nishi, K., Abe, K., Horinouchi, S.
and Beppu, T. (1990) Eﬀects of leptomycin B on the cell cycle of
ﬁbroblasts and ﬁssion yeast cells. Exp. Cell Res. 187, 150–156.
[45] Brady, S.N., Yu, Y., Maggi Jr., L.B. and Weber, J.D. (2004) ARF
impedes NPM/B23 shuttling in an Mdm2-sensitive tumor sup-
pressor pathway. Mol. Cell. Biol. 24, 9327–9338.
[46] Korgaonkar, C., Hagen, J., Tompkins, V., Frazier, A.A., Alla-
margot, C., Quelle, F.W. and Quelle, D.E. (2005) Nucleophosmin
(B23) targets ARF to nucleoli and inhibits its function. Mol. Cell.
Biol. 25, 1258–1271.
[47] Zhang, S., Hemmerich, P. and Grosse, F. (2004) Nucleolar
localization of the human telomeric repeat binding factor 2
(TRF2). J. Cell Sci. 117, 3935–3945.
[48] Kurki, S., Peltonen, K., Latonen, L., Kiviharju, T.M., Ojala,
P.M., Meek, D. and Laiho, M. (2004) Nucleolar protein NPM
interacts with HDM2 and protects tumor suppressor protein p53
from HDM2-mediated degradation. Cancer Cell 5, 465–475.
[49] Jackman, M., Kubota, Y., den Elzen, N., Hagting, A. and Pines,
J. (2002) Cyclin A- and cyclin E-Cdk complexes shuttle between
the nucleus and the cytoplasm. Mol. Biol. Cell 13, 1030–1045.
[50] Wang, W., Budhu, A., Forgues, M. and Wang, X.W. (2005)
Temporal and spatial control of nucleophosmin by the Ran–Crm1
complex in centrosome duplication. Nat. Cell Biol. 7, 823–830.
